
MaxCyte (MXCT) Latest News & Updates
Explore latest MaxCyte (MXCT) News and Updates
Stay updated on MaxCyte (MXCT) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in MaxCyte (MXCT)
Order type
Buy in
Order amount
Est. shares
0 shares
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •


Seeking Alpha •


Seeking Alpha •

GlobeNewsWire •

PennyStocks •

The Motley Fool •

InvestorPlace •

MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
GlobeNewsWire •


GlobeNewsWire •

Seeking Alpha •

GlobeNewsWire •

GlobeNewsWire •


GlobeNewsWire •


Seeking Alpha •

Seeking Alpha •

Zacks Investment Research •

GlobeNewsWire •
